Rchr
J-GLOBAL ID:202001016789699305
Update date: Nov. 25, 2024
Kurimoto Kenta
クリモト ケンタ | Kurimoto Kenta
Contact this researcher
You can send email directly to the researcher.
Affiliation and department:
大阪大学 大学院医学系研究科核医学講座
About 大阪大学 大学院医学系研究科核医学講座
Search "大阪大学 大学院医学系研究科核医学講座"
Detailed information
Job title:
特任研究員
Papers (6):
Sadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, Kenta Kurimoto, Toshihiro Sakai, Kazuhiro Takahashi, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Hiroki Kato, et al. Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial. EJNMMI radiopharmacy and chemistry. 2024. 9. 1. 29-29
Mitsuaki Tatsumi, Fumihiko Soeda, Sadahiro Naka, Kenta Kurimoto, Kazuhiro Ooe, Hideyuki Fukui, Daisuke Katayama, Tadashi Watabe, Hiroki Kato, Noriyuki Tomiyama. Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET. Frontiers in Oncology. 2022. 12
Sadahiro Naka, Tadashi Watabe, Thomas Lindner, Jens Cardinale, Kenta Kurimoto, Melissa Moore, Mitsuaki Tatsumi, Yuriko Mori, Eku Shimosegawa, Frank Valla, et al. One-pot and one-step automated radio-synthesis of [18F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experiment. EJNMMI Radiopharmacy and Chemistry. 2021. 6. 1
Tadashi Watabe, Kazuko Kaneda-Nakashima, Kazuhiro Ooe, Yuwei Liu, Kenta Kurimoto, Takashi Murai, Yuka Shidahara, Kenji Okuma, Masanori Takeuchi, Masayuki Nishide, et al. Extended single-dose toxicity study of [211At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer. Annals of nuclear medicine. 2021. 35. 6. 702-718
Sadahiro Naka, Tadashi Watabe, Kenta Kurimoto, Motohide Uemura, Fumihiko Soeda, Oliver C Neels, Klaus Kopka, Mitsuaki Tatsumi, Hiroki Kato, Norio Nonomura, et al. Automated [18F]PSMA-1007 production by a single use cassette-type synthesizer for clinical examination. EJNMMI radiopharmacy and chemistry. 2020. 5. 1. 18-18
more...
MISC (9):
仲定宏, 仲定宏, 渡部直史, LINDNER Thomas, 栗本健太, 若原正晴, MOORE Melissa, 巽光朗, 下瀬川恵久, VALLA Frank Jr, et al. カセット式合成装置を用いた[
18
F]FAPI-74製造プロセスの最適化-安定した臨床供給を目指して-. 核医学(Web). 2021. 58. Supplement
栗本健太, 仲定宏, 仲定宏, 若原正晴, 石渡喜一, 石渡喜一, 畑澤順, 加藤弘樹. ピナコールボランエステルを用いた4-[
18
F]フルオロフェニルアラニンの標識合成検討. 核医学(Web). 2021. 58. Supplement
栗本健太, 仲定宏, 仲定宏, 木下大輔, 佐藤隆史, 若原正晴, 渡部直史, 巽光朗, 松永恵子, 下瀬川恵久, et al. Examination of solid phase extraction column in formulation of
11
C acetic acid using cassette type synthesizer. 日本薬学会年会要旨集(CD-ROM). 2020. 140th (Web)
仲定宏, 仲定宏, 栗本健太, 神谷貴史, 佐々木秀隆, 渡部直史, 松永恵子, 藤埜浩一, 巽光朗, 下瀬川恵久, et al. 放射性医薬品の調製と作業環境. 核医学技術. 2020. 40
仲定宏, 仲定宏, 渡部直史, 金井泰和, 永森収志, 栗本健太, 木下大輔, 巽光朗, 下瀬川恵久, 金井好克, et al. 臨床使用に向けた新規L型アミノ酸トランスポーター1標的薬剤[
18
F]NKO-035の合成. 核医学(Web). 2020. 57. Supplement
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM